General Information


DRAVP ID  DRAVPe00219

Peptide Name   VIRIP[C6,C11,G13,G15]

Sequence  LEAIPCSIPPCVGFGKPFVF

Sequence Length  20

UniProt ID  No entry found

Source  Synthetic construct(derived from α1-antitrypsin)



Activity Information


Target Organism  HIV

Assay  ELISA

Activity 

  • [Ref.17448989]HIV-1:inhibition of virus infection in P4-CCR5 clls(IC50=0.73±0.13 µM).

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • No cytotoxicity information or data found in the reference(s) presented in this entry

Binding Target  membrane

Mechanism  The peptide can inhibit HIV-1 entry by binding to the gp41 FP and preventing its insertion into the target cell membrane.



Structure Information


PDB ID  None

Predicted Structure Download  DRAVPe00219

Linear/Cyclic  Cyclic

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  Disulfide bond between Cys6 and Cys11

Stereochemistry  L



Physicochemical Information


Formula  C102H153N21O24S2

Absent amino acids  DHMNQRTWY

Common amino acids  P

Mass  2121.58

Pl  5.99

Basic residues  1

Acidic residues  1

Hydrophobic residues  9

Net charge  0

Boman Index  2227

Hydrophobicity  105

Aliphatic Index  92.5

Half Life 

  •     Mammalian:5.5 hour
  •     Yeast:3 min
  •     E.coli:2 min

Extinction Coefficient cystines  125

Absorbance 280nm  6.58

Polar residues  5



Literature Information


Literature 1

Title   Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.

Pubmed ID   17448989

Reference   Cell. 2007 Apr 20;129(2):263-75.

Author   Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.

DOI   10.1016/j.cell.2007.02.042